Vogt-Koyanagi-Harada disease like presentation in patients with chronic myeloid leukemia

CML patients can have features similar to VKH even during stable hematological phase and may be possibly associated with the use of tyrosine kinase inhibitors. Hence it is important not to misdiagnose and treat such patients with long term immunomodulators.